ADHERENCE TO AND DAMAGE OF ENDOTHELIAL-CELLS BY CRYPTOCOCCUS-NEOFORMANS IN-VITRO - ROLE OF THE CAPSULE

被引:62
作者
IBRAHIM, AS
FILLER, SG
ALCOULOUMRE, MS
KOZEL, TR
EDWARDS, JE
GHANNOUM, MA
机构
[1] UNIV CALIF LOS ANGELES,HARBOR RES & EDUC INST,ST JOHNS CARDIOVASC RES CTR,DEPT INTERNAL MED,TORRANCE,CA 90509
[2] UNIV CALIF LOS ANGELES,SCH MED,LOS ANGELES,CA 90024
[3] UNIV NEVADA,DEPT MICROBIOL,RENO,NV 89557
[4] UNIV NEVADA,PROGRAM MOLEC & CELL BIOL,RENO,NV 89557
关键词
D O I
10.1128/IAI.63.11.4368-4374.1995
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Escape from the intravascular compartment is likely a critical step in the development of hematogenously disseminated cryptococcal infections, such as meningitis. The capsule of Cryptococcus neoformans is considered to be a virulence factor because of its antiphagocytic properties. To further investigate the role of the capsule in escape from the intravascular compartment, we used isogenic strain pairs, an acapsular mutant, and an encapsulated clinical isolate to determine the effects of the capsule of C. neoformans on adherence to, phagocytosis by, and damage of endothelial cells in vitro. Acapsular C. neoformans adhered significantly more to endothelial cells and caused greater endothelial cell injury than did encapsulated organisms. Coating of an acapsular strain with cryptococcal glucuronoxylomannan decreased both adherence to and damage of endothelial cells by 61.7% +/- 9.1% and 76.6% +/- 10.2%, respectively. Transmission electron microscopy demonstrated internalization of acapsular, but not encapsulated, organisms by endothelial cells. Internalization of an acapsular strain occurred through endothelial cell phagocytosis and was inhibited by cytochalasin D. Phagocytosis required a heat-labile serum factor, probably complement. These results suggest that acapsular or poorly encapsulated C. neoformans may be the form(s) that escapes from the vasculature during initiation of hematogenously disseminated disease.
引用
收藏
页码:4368 / 4374
页数:7
相关论文
共 37 条
  • [1] 25 YEARS WITH CRYPTOCOCCUS-NEOFORMANS
    BULMER, GS
    [J]. MYCOPATHOLOGIA, 1990, 109 (02) : 111 - 122
  • [2] CRYPTOCOCCUS NEOFORMANS .I. NONENCAPSULATED MUTANTS
    BULMER, GS
    SANS, MD
    GUNN, CM
    [J]. JOURNAL OF BACTERIOLOGY, 1967, 94 (05) : 1475 - &
  • [3] EXTRACELLULAR DEOXYRIBONUCLEASE PRODUCTION BY YEASTS
    CAZIN, J
    KOZEL, TR
    LUPAN, DM
    BURT, WR
    [J]. JOURNAL OF BACTERIOLOGY, 1969, 100 (02) : 760 - &
  • [4] FACILITATED ISOLATION, PURIFICATION, AND ANALYSIS OF GLUCURONOXYLOMANNAN OF CRYPTOCOCCUS-NEOFORMANS
    CHERNIAK, R
    MORRIS, LC
    ANDERSON, BC
    MEYER, SA
    [J]. INFECTION AND IMMUNITY, 1991, 59 (01) : 59 - 64
  • [5] FACTORS INFLUENCING KILLING OF CRYPTOCOCCUS-NEOFORMANS BY HUMAN LEUKOCYTES IN-VITRO
    DIAMOND, RD
    ROOT, RK
    BENNETT, JE
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1972, 125 (04) : 367 - &
  • [6] FARHI F, 1970, Infection and Immunity, V1, P526
  • [7] PENETRATION AND DAMAGE OF ENDOTHELIAL-CELLS BY CANDIDA-ALBICANS
    FILLER, SG
    SWERDLOFF, JN
    HOBBS, C
    LUCKETT, PM
    [J]. INFECTION AND IMMUNITY, 1995, 63 (03) : 976 - 983
  • [8] FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0
  • [9] DECREASED VIRULENCE IN STABLE, ACAPSULAR MUTANTS OF CRYPTOCOCCUS-NEOFORMANS
    FROMTLING, RA
    SHADOMY, HJ
    JACOBSON, ES
    [J]. MYCOPATHOLOGIA, 1982, 79 (01) : 23 - 29
  • [10] MODULATION OF INTERACTIONS OF CANDIDA-ALBICANS AND ENDOTHELIAL-CELLS BY FLUCONAZOLE AND AMPHOTERICIN-B
    GHANNOUM, MA
    FILLER, SG
    IBRAHIM, AS
    FU, Y
    EDWARDS, JE
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (10) : 2239 - 2244